Targeting apoptosis in cancer therapy

BA Carneiro, WS El-Deiry - Nature reviews Clinical oncology, 2020 - nature.com
For over three decades, a mainstay and goal of clinical oncology has been the development
of therapies promoting the effective elimination of cancer cells by apoptosis. This …

The AAA+ superfamily: a review of the structural and mechanistic principles of these molecular machines

YA Khan, KI White, AT Brunger - Critical reviews in biochemistry …, 2022 - Taylor & Francis
ATPases associated with diverse cellular activities (AAA+ proteins) are a superfamily of
proteins found throughout all domains of life. The hallmark of this family is a conserved …

Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment

X Chen, C Glytsou, H Zhou, S Narang, DE Reyna… - Cancer discovery, 2019 - AACR
The BCL2 family plays important roles in acute myeloid leukemia (AML). Venetoclax, a
selective BCL2 inhibitor, has received FDA approval for the treatment of AML. However …

[HTML][HTML] A high-density human mitochondrial proximity interaction network

H Antonicka, ZY Lin, A Janer, MJ Aaltonen… - Cell metabolism, 2020 - cell.com
We used BioID, a proximity-dependent biotinylation assay with 100 mitochondrial baits from
all mitochondrial sub-compartments, to create a high-resolution human mitochondrial …

Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders

A Stray-Pedersen, HS Sorte, P Samarakoon… - Journal of Allergy and …, 2017 - Elsevier
Background Primary immunodeficiency diseases (PIDDs) are clinically and genetically
heterogeneous disorders thus far associated with mutations in more than 300 genes. The …

[HTML][HTML] Genomic diagnosis for children with intellectual disability and/or developmental delay

KM Bowling, ML Thompson, MD Amaral, CR Finnila… - Genome medicine, 2017 - Springer
Background Developmental disabilities have diverse genetic causes that must be identified
to facilitate precise diagnoses. We describe genomic data from 371 affected individuals, 309 …

[HTML][HTML] New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre

E Pronicka, D Piekutowska-Abramczuk, E Ciara… - Journal of translational …, 2016 - Springer
Background Whole-exome sequencing (WES) has led to an exponential increase in
identification of causative variants in mitochondrial disorders (MD). Methods We performed …

Mitochondrial dysfunction and seizures: the neuronal energy crisis

G Zsurka, WS Kunz - The Lancet Neurology, 2015 - thelancet.com
Seizures are often the key manifestation of neurological diseases caused by pathogenic
mutations in 169 of the genes that have so far been identified to affect mitochondrial …

Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history

J Donadieu, B Beaupain, O Fenneteau… - British journal of …, 2017 - Wiley Online Library
This review focuses on the classification, diagnosis and natural history of congenital
neutropenia (CN). CN encompasses a number of genetic disorders with chronic neutropenia …

[HTML][HTML] HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation

Y Fan, M Murgia, MI Linder… - The Journal of …, 2022 - Am Soc Clin Investig
The relevance of molecular mechanisms governing mitochondrial proteostasis to the
differentiation and function of hematopoietic and immune cells is largely elusive. Through …